Ron A. A. Mathôt

Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis

Johannan F. Brandse, Gijs R. van den Brink, Manon E. Wildenberg et al. · Gastroenterology · 2015 · 410 citations

Inflammation, Chronic Inflammatory Diseases, Functional Gastrointestinal Disorder +6

Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial

Sil Kordes, Michaël Pollak, Aeilko H. Zwinderman et al. · The Lancet Oncology · 2015 · 372 citations

Placebo-controlled Phase 2, Oncology, Pancreatic Cancer +8

Cyclosporine Interacts with Mycophenolic Acid by Inhibiting the Multidrug Resistance-Associated Protein 2

Dennis A. Hesselink, Reinier M. van Hest, Ron A. A. Mathôt et al. · American Journal of Transplantation · 2005 · 297 citations

Signal Transduction, Biochemistry, Mycophenolic Acid +6

Determinants of drug absorption in different ECMO circuits

Enno D. Wildschut, Maurice J. Ahsman, Karel Allegaert et al. · Intensive Care Medicine · 2010 · 246 citations · Full text

Impact of Goal-Oriented and Model-Based Clinical Pharmacokinetic Dosing of Aminoglycosides on Clinical Outcome: A Cost-Effectiveness Analysis

Nicolette A. E. M. van Lent-Evers, Ron A. A. Mathôt, W. P. Geus et al. · Therapeutic Drug Monitoring · 1999 · 243 citations